HYBRID PEPTIDE A NOVEL CLINICAL FRONTIER

Chimera sequences represent a significantly developing area in drug exploration, providing a distinct strategy to treat previously intractable illnesses. These synthetic structures merge several protein regions, allowing for optimized affinity to several sites and maybe overcoming therapeutic tol